62 related articles for article (PubMed ID: 28699202)
1. Ductal adenocarcinoma of the prostate: Clinical and biological profiles.
Vinceneux A; Bruyère F; Haillot O; Charles T; de la Taille A; Salomon L; Allory Y; Ouzaid I; Choudat L; Rouprêt M; Comperat E; Houede N; Beauval JB; Vourc'h P; Fromont G
Prostate; 2017 Sep; 77(12):1242-1250. PubMed ID: 28699202
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
Lotan TL; Gumuskaya B; Rahimi H; Hicks JL; Iwata T; Robinson BD; Epstein JI; De Marzo AM
Mod Pathol; 2013 Apr; 26(4):587-603. PubMed ID: 23222491
[TBL] [Abstract][Full Text] [Related]
3. Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.
Ranasinha N; Omer A; Philippou Y; Harriss E; Davies L; Chow K; Chetta PM; Erickson A; Rajakumar T; Mills IG; Bryant RJ; Hamdy FC; Murphy DG; Loda M; Hovens CM; Corcoran NM; Verrill C; Lamb AD
BJUI Compass; 2021 Jan; 2(1):13-23. PubMed ID: 35474657
[TBL] [Abstract][Full Text] [Related]
4. Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.
Zara Rozalen A; Martin JM; Rajendran R; Jain M; Nava VE
Curr Oncol; 2024 Mar; 31(3):1556-1561. PubMed ID: 38534951
[TBL] [Abstract][Full Text] [Related]
5. Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors.
Jeong SU; Kekatpure AK; Park JM; Han M; Hwang HS; Jeong HJ; Go H; Cho YM
J Pathol Transl Med; 2017 Sep; 51(5):471-481. PubMed ID: 28793393
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.
Segalés L; Juanpere N; Gallarín N; Lorenzo M; López D; Perera-Bel J; Rodriguez-Vida A; Fumadó L; Cecchini L; Bellmunt J; Lloreta-Trull J; Hernández-Llodrà S
Virchows Arch; 2023 Nov; ():. PubMed ID: 38017230
[TBL] [Abstract][Full Text] [Related]
7. Renal Function Parameters in Distinctive Molecular Subtypes of Prostate Cancer.
Timofte AD; Caruntu ID; Covic AC; Hancianu M; Girlescu N; Chifu MB; Giusca SE
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894380
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the Management of Rare Kidney Cancers.
Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
[TBL] [Abstract][Full Text] [Related]
9. Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.
Beltran H; Wyatt AW; Chedgy EC; Donoghue A; Annala M; Warner EW; Beja K; Sigouros M; Mo F; Fazli L; Collins CC; Eastham J; Morris M; Taplin ME; Sboner A; Halabi S; Gleave ME
Clin Cancer Res; 2017 Nov; 23(22):6802-6811. PubMed ID: 28842510
[No Abstract] [Full Text] [Related]
10. Molecular alterations in prostate cancer and association with MRI features.
Lee D; Fontugne J; Gumpeni N; Park K; MacDonald TY; Robinson BD; Sboner A; Rubin MA; Mosquera JM; Barbieri CE
Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):430-435. PubMed ID: 28762374
[TBL] [Abstract][Full Text] [Related]
11. Focal cryotherapy: step by step technique description.
Redondo C; Srougi V; da Costa JB; Baghdad M; Velilla G; Nunes-Silva I; Bergerat S; Garcia-Barreras S; Rozet F; Ingels A; Galiano M; Sanchez-Salas R; Barret E; Cathelineau X
Int Braz J Urol; 2017; 43(5):995-996. PubMed ID: 28727387
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.
Spratt DE; Dess RT; Zumsteg ZS; Lin DW; Tran PT; Morgan TM; Antonarakis ES; Nguyen PL; Ryan CJ; Sandler HM; Cooperberg MR; Posadas E; Feng FY
Eur Urol; 2018 Feb; 73(2):156-165. PubMed ID: 28716370
[TBL] [Abstract][Full Text] [Related]
13. Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.
Patel HD; Tosoian JJ; Carter HB; Epstein JI
JAMA Oncol; 2018 Jan; 4(1):89-92. PubMed ID: 28715578
[TBL] [Abstract][Full Text] [Related]
14. Erectile function after stereotactic body radiotherapy for localized prostate cancer.
Dess RT; Hartman HE; Aghdam N; Jackson WC; Soni PD; Abugharib AE; Suy S; Desai NB; Zumsteg ZS; Mehra R; Morgan TM; Feng FY; Hamstra DA; Schipper MJ; Collins SP; Spratt DE
BJU Int; 2018 Jan; 121(1):61-68. PubMed ID: 28710895
[TBL] [Abstract][Full Text] [Related]
15. Validation of Prostate Imaging Reporting and Data System Version 2 Using an MRI-Ultrasound Fusion Biopsy in Prostate Cancer Diagnosis.
Kim SH; Choi MS; Kim MJ; Kim YH; Cho SH
AJR Am J Roentgenol; 2017 Oct; 209(4):800-805. PubMed ID: 28705064
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions.
Lewis S; Besa C; Rosen A; Rastinehad AR; Semaan S; Hectors S; Taouli B
Abdom Radiol (NY); 2017 Nov; 42(11):2732-2744. PubMed ID: 28702787
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study.
Li G; Sun K; Guo J; Li S; Li B; Cao J; Lu P; Yang J; Zhang Y; Yang X; Gao L; He Y; Cui T; Ma B
Sci Rep; 2017 Jul; 7(1):5229. PubMed ID: 28701750
[TBL] [Abstract][Full Text] [Related]
18. PIN-like (Ductal) Adenocarcinoma of the Prostate.
Paulk A; Giannico G; Epstein JI
Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
[TBL] [Abstract][Full Text] [Related]
19. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.
Zhou M
Mod Pathol; 2018 Jan; 31(S1):S71-79. PubMed ID: 29297491
[TBL] [Abstract][Full Text] [Related]
20. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
Samaratunga H; Delahunt B; Egevad L; Srigley JR; Billis A; Bostwick DG; Camparo P; Cheng L; Clouston D; Denham J; Furusato B; Hartmann A; Jufe L; Kench J; Kenwright DN; Kristiansen G; Leite KRM; MacLennan GT; Merrimen J; Moch H; Oxley J; Pan CC; Paner G; Ro J; Sesterhenn IAM; Shanks J; Thunders M; Tsuzuki T; Wheeler T; Yaxley JW; Varma M
Pathology; 2020 Feb; 52(2):192-196. PubMed ID: 31843189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
